Juvenile Idiopathic Arthritis (JIA) remains the most common systemic disorder associated with
pediatric uveitis. Studies estimate that 28-67% of patients with JIA-associated uveitis
develop ocular complications, with 12% developing poor visual outcome. The only means of
improving long term effects of uveitis, is early and aggressive anti-inflammatory treatment,
including biologics.